Plimoth Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $382K | Hold |
6,920
| – | – | 0.09% | 133 |
|
|
2025
Q4 | $339K | Hold |
6,920
| – | – | 0.08% | 145 |
|
|
2025
Q3 | $299K | Hold |
6,920
| – | – | 0.07% | 147 |
|
|
2025
Q2 | $266K | Hold |
6,920
| – | – | 0.06% | 155 |
|
|
2025
Q1 | $268K | Hold |
6,920
| – | – | 0.07% | 152 |
|
|
2024
Q4 | $234K | Hold |
6,920
| – | – | 0.06% | 151 |
|
|
2024
Q3 | $283K | Hold |
6,920
| – | – | 0.07% | 146 |
|
|
2024
Q2 | $266K | Hold |
6,920
| – | – | 0.07% | 147 |
|
|
2024
Q1 | $297K | Hold |
6,920
| – | – | 0.08% | 144 |
|
|
2023
Q4 | $256K | Hold |
6,920
| – | – | 0.07% | 149 |
|
|
2023
Q3 | $251K | Hold |
6,920
| – | – | 0.08% | 147 |
|
|
2023
Q2 | $247K | Hold |
6,920
| – | – | 0.07% | 151 |
|
|
2023
Q1 | $246K | Hold |
6,920
| – | – | 0.08% | 153 |
|
|
2022
Q4 | $243K | Hold |
6,920
| – | – | 0.08% | 154 |
|
|
2022
Q3 | $204K | Hold |
6,920
| – | – | 0.07% | 154 |
|
|
2022
Q2 | $377K | Hold |
6,920
| – | – | 0.12% | 134 |
|
|
2022
Q1 | $377K | Hold |
6,920
| – | – | 0.1% | 142 |
|
|
2021
Q4 | $381K | Hold |
6,920
| – | – | 0.1% | 142 |
|
|
2021
Q3 | $331K | Sell |
6,920
-200
| -3% | -$10K | 0.09% | 144 |
|
|
2021
Q2 | $354K | Hold |
7,120
| – | – | 0.1% | 141 |
|
|
2021
Q1 | $318K | Sell |
7,120
-40
| -0.6% | -$1.82K | 0.09% | 146 |
|
|
2020
Q4 | $329K | Hold |
7,160
| – | – | 0.1% | 139 |
|
|
2020
Q3 | $337K | Hold |
7,160
| – | – | 0.11% | 136 |
|
|
2020
Q2 | $365K | Sell |
7,160
-1,034
| -13% | -$53K | 0.13% | 134 |
|
|
2020
Q1 | $388K | Sell |
8,194
-180
| -2% | -$9.6K | 0.16% | 127 |
|
|
2019
Q4 | $491K | Hold |
8,374
| – | – | 0.16% | 140 |
|
|
2019
Q3 | $447K | Hold |
8,374
| – | – | 0.15% | 147 |
|
|
2019
Q2 | $419K | Sell |
8,374
-440
| -5% | -$22.1K | 0.14% | 151 |
|
|
2019
Q1 | $460K | Sell |
8,814
-1,036
| -11% | -$51.8K | 0.15% | 140 |
|
|
2018
Q4 | $470K | Sell |
9,850
-812
| -8% | -$40K | 0.17% | 137 |
|
|
2018
Q3 | $536K | Sell |
10,662
-176
| -2% | -$8.94K | 0.17% | 139 |
|
|
2018
Q2 | $546K | Hold |
10,838
| – | – | 0.19% | 132 |
|
|
2018
Q1 | $530K | Buy |
+10,838
| New | +$505K | 0.18% | 134 |
|
Other funds holding GSK
JEST
Plimoth Trust's GSK Position: Q1 2026 in Review
Plimoth Trust held its GSK (GSK) position steady in Q1 2026 at 6,920 shares worth $382K. The position accounts for 0.09% of the portfolio, ranked #133.
Plimoth Trust first reported a position in GSK in Q1 2018 and has held it in 33 quarters since. The position peaked at $546K in Q2 2018. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Plimoth Trust held 6,920 shares of GSK worth $382K as of Q1 2026.
- Plimoth Trust left its GSK share count unchanged in Q1 2026.
- GSK made up 0.09% of Plimoth Trust's portfolio in Q1 2026, its #133 holding.
- Plimoth Trust first reported a position in GSK in Q1 2018 and has held it in 33 quarters since.
- Plimoth Trust's GSK position peaked at $546K in Q2 2018.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Plimoth Trust's 13F filing for Q1 2026, filed 27 Apr 2026.